消除加瘤病的现状和挑战:系统性审查
Elsa-Rush Eyang-Assengone1, Patrice Makouloutou-Nzassi1,2, Clark Mbou-Boutambe1
1Unité de Recherche en Ecologie de la Santé (URES), Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF), Franceville BP 769, Gabon.
Microorganisms
|August 26, 2023
概括
加缺乏瘤病控制计划,研究有限,疾病分布不均. 了解疾病的理解.
科学领域:
- 热带医学是一种热带医学.
- 寄生虫学的寄生虫学
- 公共卫生 公共卫生
背景情况:
- 瘤病控制和治疗计划 (CDTI) 已在流行国家建立.
- 加在实施有效的肉病控制计划方面面临挑战.
- 之前在加对瘤病的研究是有限的,并且在地理上集中.
研究的目的:
- 为了绘制在加的瘤病的分布图.
- 总结国内关于瘤病的现有研究.
- 确定消除疾病的挑战和潜在热点.
主要方法:
- 系统审查数据库文章关于瘤病,动物水库,监测和消除在加.
- 分析不同地区和部门的流行数据.
- 对载体活动研究的审查.
主要成果:
- 研究很少,主要集中在拉斯托维尔地区.
- 在整个加,瘤病的发病率有很大差异,确定了超特有,中特有和低特有地区.
- 一些省份的流行率从0%到20%以上,村庄的感染率在10%到60%,表明潜在的热点.
- 关于载体活动的数据有限.
结论:
- 加需要建立强有力的瘤病控制计划.
- 对疾病生物生态学的更深入的理解对于有效的卫生政策至关重要.
- 有针对性的干预措施是必要的,以解决疾病热点,并努力消除.
相关概念视频
Methods Of Healthcare Delivery System
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


